We are live on ! Find out more
ANGO icon

AngioDynamics

164 hedge funds and large institutions have $626M invested in AngioDynamics in 2018 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 67 increasing their positions, 48 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 48

1.09% more ownership

Funds ownership: 97.69%98.78% (+1.1%)

5% more capital invested

Capital invested by funds: $597M → $626M (+$29.7M)

3% less funds holding

Funds holding: 169164 (-5)

13% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 23

99% less call options, than puts

Call options by funds: $4K | Put options by funds: $462K

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
164
Holders Change
-5
Holders Change %
-2.96%
% of All Funds
3.76%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
20
Increased
67
Reduced
48
Closed
23
Calls
$4K
Puts
$462K
Net Calls
-$458K
Net Calls Change
-$461K
Name Holding Trade Value Shares
Change
Change in
Stake
HA
26
Heartland Advisors
Wisconsin
$5.99M +$5.79M +347,249 New
Prudential Financial
27
Prudential Financial
New Jersey
$5.84M -$303K -18,146 -5%
Charles Schwab
28
Charles Schwab
California
$5.28M -$910K -54,580 -15%
Principal Financial Group
29
Principal Financial Group
Iowa
$5.14M +$131K +7,871 +3%
GLA
30
Great Lakes Advisors
Illinois
$4.5M -$18.8K -1,127 -0.4%
American Century Companies
31
American Century Companies
Missouri
$4.11M -$1.39M -83,560 -26%
AIM
32
Alambic Investment Management
California
$4.03M +$545K +32,700 +16%
Invesco
33
Invesco
Georgia
$3.98M +$1.1M +65,696 +40%
MAM
34
Martingale Asset Management
Massachusetts
$3.91M +$91.8K +5,503 +2%
Axa
35
Axa
France
$3.81M
Millennium Management
36
Millennium Management
New York
$3.79M +$3.66M +219,512 New
Jacobs Levy Equity Management
37
Jacobs Levy Equity Management
New Jersey
$3.7M +$357K +21,402 +11%
BCM
38
Bridgeway Capital Management
Texas
$3.58M +$1.16M +69,500 +50%
TCIM
39
TIAA CREF Investment Management
New York
$3.39M -$908K -54,447 -22%
OAM
40
Oxford Asset Management
United Kingdom
$3.32M +$440K +26,357 +16%
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$3.26M -$263K -15,746 -8%
Nordea Investment Management
42
Nordea Investment Management
Sweden
$3.15M +$638K +38,269 +27%
Morgan Stanley
43
Morgan Stanley
New York
$3.04M +$716K +42,913 +32%
Two Sigma Advisers
44
Two Sigma Advisers
New York
$3M -$530K -31,788 -15%
AL
45
AJO LP
Pennsylvania
$2.78M +$2.68M +160,908 New
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$2.69M -$311K -18,670 -11%
Deutsche Bank
47
Deutsche Bank
Germany
$2.54M +$1.07M +64,095 +77%
AllianceBernstein
48
AllianceBernstein
Tennessee
$2.46M -$457K -27,370 -16%
Citadel Advisors
49
Citadel Advisors
Florida
$2.41M +$326K +19,553 +16%
SFM
50
Systematic Financial Management
New Jersey
$2.23M -$2.84M -170,275 -57%

ANGO Hedge Fund Activity: Q1 2018 in Review

164 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q1 2018, worth a combined $626M — up 5% from $597M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of ANGO and 20 opened new positions — a net loss of 3 holders — while 48 trimmed existing stakes and 67 added.

The largest buyer was JP Morgan Chase, adding an estimated $13.5M. The largest seller was Broadfin Capital, cutting an estimated $13.7M.

  • 164 institutional investors held AngioDynamics (ANGO) as of Q1 2018, down from 169 in Q4 2017.
  • Funds reported $626M of AngioDynamics stock for Q1 2018, up 5% quarter-over-quarter.
  • 20 funds opened new AngioDynamics positions in Q1 2018 and 23 closed out, a net change of -3 holders.
  • The largest AngioDynamics buyer in Q1 2018 was JP Morgan Chase, an estimated $13.5M added.
  • The largest AngioDynamics seller in Q1 2018 was Broadfin Capital, an estimated $13.7M sold.

Based on aggregated 13F filings for Q1 2018.